お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
974073

世界の前立腺生検市場(2020年~2024年)

Global Prostate Biopsy Market 2020-2024

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.58円
世界の前立腺生検市場(2020年~2024年)
出版日: 2020年11月23日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の前立腺生検の市場規模は、2020年から2024年の間に3億8,023万米ドル成長し、予測期間中に11%のCAGRで推移する見込みです。同市場は、前立腺がんの発生率の増加と診断センターの数の増加によって推進されています。

当レポートでは、前立腺生検市場を調査し、市場概要、市場の成長要因および阻害要因の分析、製品別・エンドユーザー別・地域別の市場規模の推移と予測、ベンダー分析、市場機会など、包括的な情報を提供しています。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模2019
  • 市場の見通し:2019年から2024年の予測

ファイブフォース分析

製品別の市場セグメンテーション

  • 市場セグメンテーション
  • 製品別比較
  • 前立腺針生検-市場規模と予測(2019年-2024年)
  • 前立腺リキッドバイオプシー-市場規模と予測(2019年-2024年)
  • 製品別の市場機会

エンドユーザー別市場セグメンテーション

  • 市場セグメンテーション
  • エンドユーザー別比較
  • 病院-市場規模と予測(2019年-2024年)
  • ASC-市場規模と予測(2019年-2024年)
  • 診断センター-市場規模と予測(2019年-2024年)
  • エンドユーザー別市場機会

顧客情勢

地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米-市場規模と予測(2019年-2024年)
  • 欧州-市場規模と予測(2019年-2024年)
  • アジア-市場規模と予測(2019年-2024年)
  • その他の地域-市場規模と予測(2019年-2024年)
  • 主要な主要国
  • 地域の市場機会
  • 市場の推進力
  • 市場の課題
  • 市場動向

ベンダー情勢

  • 概要
  • ベンダー情勢
  • 創造的破壊の状況

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Bio-Techne Corp.
  • Boston Scientific Corp.
  • Cook Group Inc.
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health Inc.
  • PURE Medical Device SA
  • QIAGEN NV
  • SOMATEX Medical Technologies GmbH
  • Thermo Fisher Scientific Inc.

付録

目次
Product Code: IRTNTR45756

Technavio has been monitoring the prostate biopsy market and it is poised to grow by $ 380.23 mn during 2020-2024, progressing at a CAGR of 11% during the forecast period. Our reports on the prostate biopsy market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing incidences of prostate cancer and the growing number of diagnostic centers. In addition, growing incidences of prostate cancer is anticipated to boost the growth of the market as well.

The prostate biopsy market analysis includes product segment and geographical landscapes.

Technavio's prostate biopsy market is segmented as below:

By Product

  • Prostate needle biopsy
  • Prostate liquid biopsy

By Geographical Landscapes

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the recurrent revenue from repeat biopsy tests as one of the prime reasons driving the prostate biopsy market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our prostate biopsy market report covers the following areas:

  • Prostate biopsy market sizing
  • Prostate biopsy market forecast
  • Prostate biopsy market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading prostate biopsy market vendors that include Becton, Dickinson and Co., Bio-Techne Corp., Boston Scientific Corp., Cook Group Inc., F. Hoffmann-La Roche Ltd., Guardant Health Inc., PURE Medical Device SA, QIAGEN NV, SOMATEX Medical Technologies GmbH, and Thermo Fisher Scientific Inc. Also, the prostate biopsy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Prostate needle biopsy - Market size and forecast 2019-2024
  • Prostate liquid biopsy - Market size and forecast 2019-2024
  • Market opportunity by Product

Market Segmentation by End user

  • Market segments
  • Comparison by End user
  • Hospitals - Market size and forecast 2019-2024
  • ASCs - Market size and forecast 2019-2024
  • Diagnostic centers - Market size and forecast 2019-2024
  • Market opportunity by End user

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Bio-Techne Corp.
  • Boston Scientific Corp.
  • Cook Group Inc.
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health Inc.
  • PURE Medical Device SA
  • QIAGEN NV
  • SOMATEX Medical Technologies GmbH
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Key Finding 9
  • 9: Parent market
  • 10: Market characteristics
  • 11: Offerings of vendors included in the market definition
  • 12: Market segments
  • 13: Global - Market size and forecast 2019 - 2024 ($ million)
  • 14: Global market: Year-over-year growth 2019 - 2024 (%)
  • 15: Five forces analysis 2019 & 2024
  • 16: Bargaining power of buyers
  • 17: Bargaining power of suppliers
  • 18: Threat of new entrants
  • 19: Threat of substitutes
  • 20: Threat of rivalry
  • 21: Market condition - Five forces 2019
  • 22: Product - Market share 2019-2024 (%)
  • 23: Comparison by Product
  • 24: Prostate needle biopsy - Market size and forecast 2019-2024 ($ million)
  • 25: Prostate needle biopsy - Year-over-year growth 2019-2024 (%)
  • 26: Prostate liquid biopsy - Market size and forecast 2019-2024 ($ million)
  • 27: Prostate liquid biopsy - Year-over-year growth 2019-2024 (%)
  • 28: Market opportunity by Product
  • 29: End user - Market share 2019-2024 (%)
  • 30: Comparison by End user
  • 31: Hospitals - Market size and forecast 2019-2024 ($ million)
  • 32: Hospitals - Year-over-year growth 2019-2024 (%)
  • 33: ASCs - Market size and forecast 2019-2024 ($ million)
  • 34: ASCs - Year-over-year growth 2019-2024 (%)
  • 35: Diagnostic centers - Market size and forecast 2019-2024 ($ million)
  • 36: Diagnostic centers - Year-over-year growth 2019-2024 (%)
  • 37: Market opportunity by End user
  • 38: Customer landscape
  • 39: Market share by geography 2019-2024 (%)
  • 40: Geographic comparison
  • 41: North America - Market size and forecast 2019-2024 ($ million)
  • 42: North America - Year-over-year growth 2019-2024 (%)
  • 43: Europe - Market size and forecast 2019-2024 ($ million)
  • 44: Europe - Year-over-year growth 2019-2024 (%)
  • 45: Asia - Market size and forecast 2019-2024 ($ million)
  • 46: Asia - Year-over-year growth 2019-2024 (%)
  • 47: ROW - Market size and forecast 2019-2024 ($ million)
  • 48: ROW - Year-over-year growth 2019-2024 (%)
  • 49: Key leading countries
  • 50: Market opportunity by geography ($ million)
  • 51: Impact of drivers and challenges
  • 52: Vendor landscape
  • 53: Landscape disruption
  • 54: Industry risks
  • 55: Vendors covered
  • 56: Market positioning of vendors
  • 57: Becton, Dickinson and Co. - Overview
  • 58: Becton, Dickinson and Co. - Business segments
  • 59: Becton, Dickinson and Co. - Key offerings
  • 60: Becton, Dickinson and Co. - Key customers
  • 61: Becton, Dickinson and Co. - Segment focus
  • 62: Bio-Techne Corp. - Overview
  • 63: Bio-Techne Corp. - Business segments
  • 64: Bio-Techne Corp. - Key offerings
  • 65: Bio-Techne Corp. - Key customers
  • 66: Bio-Techne Corp. - Segment focus
  • 67: Boston Scientific Corp. - Overview
  • 68: Boston Scientific Corp. - Business segments
  • 69: Boston Scientific Corp. - Key offerings
  • 70: Boston Scientific Corp. - Key customers
  • 71: Boston Scientific Corp. - Segment focus
  • 72: Cook Group Inc. - Overview
  • 73: Cook Group Inc. - Product and service
  • 74: Cook Group Inc. - Key offerings
  • 75: Cook Group Inc. - Key customers
  • 76: Cook Group Inc. - Segment focus
  • 77: F. Hoffmann-La Roche Ltd. - Overview
  • 78: F. Hoffmann-La Roche Ltd. - Business segments
  • 79: F. Hoffmann-La Roche Ltd. - Key offerings
  • 80: F. Hoffmann-La Roche Ltd. - Key customers
  • 81: F. Hoffmann-La Roche Ltd. - Segment focus
  • 82: Guardant Health Inc. - Overview
  • 83: Guardant Health Inc. - Business segments
  • 84: Guardant Health Inc. - Key offerings
  • 85: Guardant Health Inc. - Key customers
  • 86: Guardant Health Inc. - Segment focus
  • 87: PURE Medical Device SA - Overview
  • 88: PURE Medical Device SA - Product and service
  • 89: PURE Medical Device SA - Key offerings
  • 90: PURE Medical Device SA - Key customers
  • 91: PURE Medical Device SA - Segment focus
  • 92: QIAGEN NV - Overview
  • 93: QIAGEN NV - Business segments
  • 94: QIAGEN NV - Key offerings
  • 95: QIAGEN NV - Key customers
  • 96: QIAGEN NV - Segment focus
  • 97: SOMATEX Medical Technologies GmbH - Overview
  • 98: SOMATEX Medical Technologies GmbH - Product and service
  • 99: SOMATEX Medical Technologies GmbH - Key offerings
  • 100: SOMATEX Medical Technologies GmbH - Key customers
  • 101: SOMATEX Medical Technologies GmbH - Segment focus
  • 102: Thermo Fisher Scientific Inc. - Overview
  • 103: Thermo Fisher Scientific Inc. - Business segments
  • 104: Thermo Fisher Scientific Inc. - Key offerings
  • 105: Thermo Fisher Scientific Inc. - Key customers
  • 106: Thermo Fisher Scientific Inc. - Segment focus
  • 107: Currency conversion rates for US$
  • 108: Research Methodology
  • 109: Validation techniques employed for market sizing
  • 110: Information sources
  • 111: List of abbreviations
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.